Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5604]
News [13558]
Articles [218]
Editorials [5]
Conferences [266]
elearning [17]

The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study

Dr Chaya Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study ( Dr Chaya Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
17 Dec 2012

Neurocognitive impact in adjuvant chemotherapy for breast cancer

Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA
Neurocognitive impact in adjuvant chemotherapy for breast cancer ( Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA )
17 Dec 2012

Predicting late distant metastases in ER / HER2- breast cancer patients

Dr Peter Dubsky - Medical University of Vienna, Austria
Predicting late distant metastases in ER / HER2- breast cancer patients ( Dr Peter Dubsky - Medical University of Vienna, Austria )
17 Dec 2012

Results of a randomised phase 2 study of PD 0332991

Dr Richard Finn - Universtity of California, Los Angeles, USA
Results of a randomised phase 2 study of PD 0332991 ( Dr Richard Finn - Universtity of California, Los Angeles, USA )
17 Dec 2012

MLN9708 in combination with lenalidomide and dexamethasone against multiple myeloma

Dr Shaji Kumar - Mayo Clinic, Rochester, USA
MLN9708 in combination with lenalidomide and dexamethasone against multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
17 Dec 2012

PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid leukaemia (CML)

Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA
PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid leukaemia (CML) ( Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA )
17 Dec 2012

Influence of low penetrant factors on overall cancer risk

Prof Douglas Easton – Cancer Research UK Genetic Epidemiology Unit, Cambridge University, UK
Influence of low penetrant factors on overall cancer risk ( Prof Douglas Easton – Cancer Research UK Genetic Epidemiology Unit, Cambridge University, UK )
16 Dec 2012

Diverse genetic alterations found in triple-negative breast cancers after neoadjuvant chemo

Dr Justin Balko – Vanderbilt-Ingram Cancer Center, Nashville, USA
Diverse genetic alterations found in triple-negative breast cancers after neoadjuvant chemo ( Dr Justin Balko – Vanderbilt-Ingram Cancer Center, Nashville, USA )
16 Dec 2012

Pomalidomide with low-dose vs. high-dose dexamathasone in refractory patients

Professor Meletios Dimopoulos - University of Athens, Greece
Pomalidomide with low-dose vs. high-dose dexamathasone in refractory patients ( Professor Meletios Dimopoulos - University of Athens, Greece )
16 Dec 2012

MLN9708 in combination with lenalidomide and dexamethasone

Dr Shaji Kumar - Mayo Clinic, Rochester, USA
MLN9708 in combination with lenalidomide and dexamethasone ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
16 Dec 2012

Effects of obesity in breast cancer patients

Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA
Effects of obesity in breast cancer patients ( Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA )
14 Dec 2012

The AZURE translational study

Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK
The AZURE translational study ( Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK )
14 Dec 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation